Nuclear import machinery

The nuclear import machinery is a sophisticated multi-protein system responsible for the selective transport of proteins, RNA, and ribonucleoprotein complexes from the cytoplasm into the nucleus [1]. This process is primarily facilitated by the nuclear pore complex (NPC), a massive structure embedded in the nuclear envelope, and a family of soluble transport receptors known as karyopherins or importins [2]. Importins recognize specific nuclear localization signals (NLS) on cargo proteins and, in coordination with the Ran-GTPase cycle, ferry them through the NPC [1][3]. In various pathological states, such as cancer and viral infections, the nuclear import machinery is often dysregulated or exploited to sequester tumor suppressors in the cytoplasm or to transport viral genomes and proteins into the nucleus for replication [4][5]. Consequently, components of this machinery, particularly Importin alpha and Importin beta-1, have become attractive therapeutic targets for small-molecule inhibitors like ivermectin and importazole [6]. By disrupting these transport pathways, drugs can restore the nuclear localization of regulatory proteins or prevent viral assembly, although the essential nature of nucleocytoplasmic transport in normal cells presents significant challenges regarding systemic toxicity and therapeutic index [7].

Other names

Nucleocytoplasmic transport machineryKaryopherin-mediated transport systemImportin-alpha/beta pathwayNuclear transport system

Inhibition of karyopherin-cargo binding, disruption of the Ran-GTP gradient, or physical occlusion of the nuclear pore complex to prevent the translocation of proteins containing nuclear localization signals (NLS).